Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway.

Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway.

Item
http://www.wikidata.org/entity/Q34067009
Halofuginone Synergistically Enhances Anti-Proliferation of Rapamycin in T Cells and Reduces Cytotoxicity of Cyclosporine in Cultured Renal Tubular Epithelial CellsHalofuginone inhibits the establishment and progression of melanoma bone metastases.Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.Halofuginone down-regulates Smad3 expression and inhibits the TGFbeta-induced expression of fibrotic markers in human corneal fibroblasts.Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model.Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastasesHalofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism.Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft modelPlant-derived anticancer agents: a promising treatment for bone metastasis.Halofuginone - the multifaceted molecule.Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line.Evaluation and Elucidation Studies of Natural Aglycones for Anticancer Potential using Apoptosis-Related Markers: An In silico Study.Ubiquitin enzymes in the regulation of immune responses.The effect of antifibrotic drug halofugine on Th17 cells in concanavalin A-induced liver fibrosis.
P2860

Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway.

Item
http://www.wikidata.org/entity/Q34067009
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@ast
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@en
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@nl
type
label
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@ast
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@en
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@nl
prefLabel
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@ast
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@en
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Halofuginone has anti-prolifer ...... factor beta signaling pathway.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0026713
P407
P433
P478
P50
P577
P5875
P698
P921
P932